Overexpression of folate binding protein in ovarian cancers.
about
Targeting folate receptor alpha for cancer treatmentTargeted agents in epithelial ovarian cancer: review on emerging therapies and future developmentsA current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancerTargeted drug delivery via folate receptors in recurrent ovarian cancer: a reviewPrecision targeted therapy of ovarian cancerFacile Synthesis of Folic Acid-Modified Iron Oxide Nanoparticles for Targeted MR Imaging in Pulmonary Tumor Xenografts.The role of folate receptor alpha (FRalpha) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy.Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors.Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.Tumor cell targeting using folate-conjugated fluorescent quantum dots and receptor-mediated endocytosis.Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.Expression of folate binding protein as a prognostic factor for response to platinum-containing chemotherapy and survival in human ovarian cancer.Trial Watch: Peptide-based anticancer vaccines.Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha.Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.Targeted immunotherapy of cancer: development of antibody-induced cellular immunity.Receptor induction and targeted drug delivery: a new antileukaemia strategy.Folate receptor-α (FOLR1) expression and function in triple negative tumorsFormulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors.Cancer stratification by molecular imaging.Cryptophane-folate biosensor for (129)xe NMR.Oncolytic virotherapy for ovarian cancer.Folate-decorated nanogels for targeted therapy of ovarian cancer.Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.Characterization of the human folate receptor alpha via novel antibody-based probes.Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.Folate receptor α expression and significance in endometrioid endometrium carcinoma and endometrial hyperplasia.Detection of early primary colorectal cancer with upconversion luminescent NP-based molecular probes.Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.Folate-conjugated rapamycin slows progression of polycystic kidney diseasePopulation pharmacokinetics of farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer.Paradoxical impact of two folate receptors, FRα and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome.
P2860
Q26744215-FAF1A767-D8A5-4DC2-8B22-1787D0BE7532Q26750649-B9DDC60B-81B6-447F-8455-6B61F9621E2AQ26781856-48BEE7D6-E008-4EC9-838B-BF403690C3B5Q26828581-9102ADD6-3EA8-48CD-A7F7-15F37A0C39FBQ28078658-BD510799-9BA5-45B3-960A-623E0FB056C2Q31029465-2B382B86-E4C2-454D-8FF4-E7348A0ECCC6Q33658554-4F60DBC2-F310-4BBB-A81D-E8E5E9296F55Q33765535-ED79481E-7AF3-485A-B18B-112DDB3BCED2Q33914066-4C0A168E-39B6-40C5-BB2E-115AFCC3BC4EQ34073529-37C17E41-219A-4396-A117-54FB2FB97DC3Q34111744-FA95CC43-7E65-438B-ADA0-546C42FFCAD2Q34118033-4A2869AA-FA00-426E-9713-E98AD2A013DDQ34139674-DD04CA71-4155-453C-85C8-72B682E0535DQ34333704-D6268088-616B-4AF0-92AE-03E73B93B0B1Q34467788-CC2813C9-C38C-45B1-8ACA-DC1C084522F9Q34483345-F0D4D590-4389-46B7-8E69-506925E9E35AQ34658009-8DA1D1C7-D5A0-4DE8-94FA-D5BF01A66AD9Q34741148-D6416FC6-FF6C-4B78-9B49-D695C3B8EEE6Q34979610-04C5ED97-A1C7-443D-82EF-2389FA6C0A7DQ35084986-B15CB2CC-CC83-438A-925D-6C1EB9FB62CAQ35164785-22E2C82F-488E-4129-9827-C20E1C24ECB0Q35225064-D2F543E2-986A-4C67-B2E3-37867BA9AE6AQ35236565-B05BAFE7-27DC-4C71-B5DE-2ACD7E950DE4Q35288804-2A9CC5FA-2C17-4CE2-964F-101297F90FE0Q35380664-AFF377C0-BE88-46C2-A5B9-F5EA4E1F7396Q35464342-C5915631-6CE9-4EFE-B045-6B1121F6922AQ35597082-E2BF78FF-F169-4371-B996-AE86113F560CQ35664403-B6489B81-4FA1-4FEA-AAC3-002F163729EEQ35687951-D3549BA6-B5D1-483D-A18B-9E4D3C54C7D4Q35764371-7C7ADE74-6445-4943-A9C5-2C59D23B9A63Q35780797-CA6254B2-DE47-4047-8605-143FA3366608Q35784231-98EABE85-C2AE-4587-9B06-2008E7C34810Q35854305-878C57DE-5FD1-4DE7-8192-F1EB34A508F4Q35867780-CA51626A-70A5-4357-A704-B8D5AFCAA8DFQ35915267-5D37CDC2-1585-432A-A6DB-829126848C67Q35988675-3B41DE1B-61D5-4276-99DC-734749559ABEQ36050687-A058BB34-262A-4D33-8782-6F22D4E2FE8EQ36280381-512F2069-EA78-4128-93CF-E27E7B67A678Q36361160-6FF27329-6763-4A01-8629-4E9FAC2FC547Q36380927-AAA9EE0A-1911-4722-BF09-789274DA2D08
P2860
Overexpression of folate binding protein in ovarian cancers.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Overexpression of folate binding protein in ovarian cancers.
@ast
Overexpression of folate binding protein in ovarian cancers.
@en
Overexpression of folate binding protein in ovarian cancers.
@nl
type
label
Overexpression of folate binding protein in ovarian cancers.
@ast
Overexpression of folate binding protein in ovarian cancers.
@en
Overexpression of folate binding protein in ovarian cancers.
@nl
prefLabel
Overexpression of folate binding protein in ovarian cancers.
@ast
Overexpression of folate binding protein in ovarian cancers.
@en
Overexpression of folate binding protein in ovarian cancers.
@nl
P2093
P2860
P1476
Overexpression of folate binding protein in ovarian cancers
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F
P50
P577
1997-04-01T00:00:00Z